Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Am J Kidney Dis. 2021 Apr 20;78(3):361–368.e1. doi: 10.1053/j.ajkd.2021.01.021

Table 2.

Association of Factor Scores with Continuous eGFR Change

Unadjusted β (95% CI) Model 1* β (95% CI) Model 2** β (95% CI)
Tubule Injury/Repair (NGAL, IL-18, and YKL-40) −0.44 (−0.59, −0.28) −0.38 (−0.56, −0.21) −0.06 (−0.24, 0.12)
Tubule Injury/Fibrosis (KIM-1 and MCP-1) −0.41 (−0.57, −0.25) −0.34 (−0.50, −0.18) −0.16 (−0.33, 0.01)
Tubule Reabsorption (α1m, β2m) −0.90 (−1.06, −0.74) −0.71 (−0.87, −0.54) −0.07 (−0.25, 0.12)
Tubule Reserve/Mineral Metabolism
(UMOD, iPTH, iFGF23)
−0.94 (−1.09, −0.78) −0.96 (−1.13, −0.80) −0.58 (−0.76, −0.39)
Albumin-creatinine ratio −1.74 (−1.89, −1.58) −1.58 (−1.74, −1.42) −1.53 (−1.69, −1.36)

Percentage changein eGFRper year

*

model 1: age, sex, race, randomization arm, SBP, DBP, number of antihypertensive meds, ACEi or ARB use, diuretic use, history of CVD or HF, current smoker, BMI, LDL, total cholesterol.

**

model 2: model 1 + baseline eGFR and UACR

Each factor is modeled per SD higher. ACR was log transformed and represents a SD higher on the log scale, to provide a reference for comparison of strengths of association.